Interference of Bcl-2 with intercellular control of carcinogenesis

International Journal of Cancer

Volumn 71, Issue 4, 1997, Pages 698-704

  Jürgensmeier, Juliane M ^a,b   Bauer, Georg ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; GENE EXPRESSION; MOUSE; NONHUMAN; PREVENTION; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CELL LINE; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; DISEASE PROGRESSION; FIBROBLASTS; MICE; MICE, INBRED C3H; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSFORMING GROWTH FACTOR BETA; ULTRAVIOLET RAYS;

EID: 1842332710     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970516)71:4<698::AID-IJC30>3.0.CO;2-5     Document Type: Article

References (26)

1. BAUER, G., Elimination of transformed cells by normal cells: a novel concept for the control of carcinogenesis. Histol. Histopathol., 11, 237-255 (1996).
2. BOISE, L.H., GONZALEZ-GARCIA, M., POSTEMA, C.E., DING, L., LINDSTEN, T., TURKA, L.A., MAO, X., NUNEZ, G. and THOMPSON, C.B., Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74, 597-608 (1993).
3. BRONNER, M.P., CULLIN, C., REED, J.C. and FURTH, E.E., The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model. Amer. J. Pathol., 146, 20-26 (1995).
4. CHITTENDEN, T., HARRINGTON, E.A., O'CONNOR, R., FLEMINGTON, C., LUTZ, R.J., EVAN, G.I. and GUILD, B.C., Induction of apoptosis by the Bcl-2 homologue Bak. Nature (Lond.), 374, 733-736 (1995).
5. GRAEBER, T.G., OSMANIAN, C., JACKS, T., HOUSMAN, D.E., KOCH, C.J., LOWE, S.W. and GIACCIA, A.J., Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature (Lond.), 379, 88-91 (1996).
6. HENDERSON, S., HUEN, M., ROWE, M., DASVSON, C., JOHNSON, G. and RICKINSON, A., Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bel-2, protects human B cells from programmed cell death. Proc. nat. Acad. Sci. (Wash.), 90, 8479-8483 (1993).
7. HENDERSON, S., ROWE, M., GREGORY, C., CROOM CARTER, D., WANG, F., LONGNECKER, R., KIEFF, E. and RICKINSON, A., Induction of Bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell. 65, 1107-1116 (1991).
8. HOCKENBERY, D.M., OLTAI, Z.N., YIN, X.-M., MILLIMAN, C. and KORSMEYER, S.J., Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75, 241-251 (1993).
9. JACKSON, M.E., CAMPO, M.S. and GAUKROGER, J.M., Cooperation between papillomaviruses and chemical cofaciors in oncogenesis. Crh. Rev. Oncogenesis, 4, 211-291 (1993).
10. JACOBSEN, M.D. and RAFF, M.C., Programmed cell death and Bcl-2 protection in very low oxygen. Nuntre (Lond.), 374, 814-816 (1995).
11. JÜRGENSMEIER, J.M., HÖFLER, P. and BAUER, G., TGF-β-induced elimination of transformed fibroblasts by normal cells: independence of cell-to-cell contact and dependence on reactive oxygen species. Int. J. Oncol., 5, 525-531 (19940).
12. JÜRGENSMEIER, J.M., VIESEL, E., HÖFLER, P and BAUER, G., TGF-β-treuted normal fibroblasts eliminate transformed fibroblasts by induction ofapoptosis. Cancer Res., 54, 393-398 (1994b).
13. KANE, D.J., SARAFIAN, T.A., ANTON, R., HAHN, H., BUTLER-GRALLA, E., SELVERSTONE-VALENTINE, J., ÖRD, T. and BREDESEN, D.E., Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science, 262, 1274-1277 (1993).
14. LANGER, C. JÜRGENSMEIER, J.M. and BAUER, G., Reactive oxygen species act both at TGF-β-dependent and -independent steps during induction of apoptosis of transformed cells by normal cells. Exp. Cell Res., 222, 117-124 (1996).
15. LINDEBERG, H. and ELBROND, O., Malignant tumours in patients with a history of multiple larynseal papillomas: the significance of irradiation. Clin. Otolaryngol., 16, 149-151 (1991).
16. MELCHINGER, W., STRAUSS, S., ZUCKER, B. and BAUER, G., Antiapoptotic activity of bovine papilloma virus: implications for the control of oncogenesis. Int. J. Oncol., 9, 927-933 (1996).
17. NAIK, P., KARRIM, J. and HANAHAN, D.,The rise and fall of apoptosis during multistage tumorigenesis-Down-modulation contributes to tumor progression from angiogenic progenitors. Genes Develop., 10, 2105-2116 (1996).
18. PATHMANATHAN, R., PRASAD, U., SADLER, R., FLYNN, K. and RAAB-TRAUB, N., Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma, N. Engl. J. Med., 333, 693-698 (1995).
19. RAO, L., DEBBAS, M., SABBATINI, P., HOCKENBERY, D., KORSMEYER, S. and WHITE, E., The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc. nat. Acad. Sci. (Wash.). 89, 7742-7746 (1992).
20. REED, J.C., Bcl-2 and the regulation of programmed cell death. J. Cell Biol., 124, 1-6 (1994).
21. SCHAEFER, D., JÜRGENSMEIER, J.M. and BAUER, G., Catechol interferes with TGF-β-induced elimination of transformed cells by normal cells: implications for the survival of transformed cells during carcinogenesis. Iut. J. Cancer, 60, 520-526 (1995).
22. SEDLAK, T.W., OLTVAI, Z.N., YANG, E., WANG, K., BOISE, L.H., THOMPSON, C.B. and KORSMEYER, S.J., Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. nat. Acad. Sci. (Wash.)., 92, 7834-7838 (1995).
23. SHIMIZU, S., EGUCHI, Y., KOSAKA, H., KAMITKE, W., MATSUDA, H. and TSUJIMOTO, Y., Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature (Lond.), 374, 811-813 (1995).
24. TSUJIMOTO, Y., COSSMAN, J., JAFFE, E. and CROCE, C, Involvement of the bel-2 gene in human follicular lymphoma. Science, 228, 1440-1443 (1985).
25. VAUX, D.L., Towards an understanding of the molecular mechanism of physiological cell death. Proc. nat. Acad. Sci. (Wash.), 90, 786-789 (1993).
26. WEHRLE, I., JAKOB, A., HÖFLER, P. and BAUER, G., Transformation of murine fibroblasts by UV light and TGF-β: establishment of an autocrine TGF-β loop. Int. J. Oncol., 5, 1341-1346 (1994).